カテゴリ： MarketLine, 企業調査, 南アフリカ

Distell Group Limited：企業の戦略・SWOT・財務情報

◆英語タイトル：Distell Group Limited - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C9175
◆発行会社（調査会社）：MarketLine
◆発行日：2018年11月
◆ページ数：38
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：南アフリカ
◆産業分野：消費財
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Distell Group Limited – Strategy, SWOT and Corporate Finance Report
Summary

Distell Group Limited – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Distell Group Limited (Distell) is an investment holding company with interests in liquor-related firms. The company, through its subsidiary, is involved in the production, marketing and distribution of alcoholic beverages. It offers wines, spirits, ciders and ready-to-drink (RTD) beverages. Distell markets its products under the brands Klipdrift, Amarula, Gordon’s, Tassenberg, Durbanville Hills, Nederburg, Drostdy-Hof, Savanna, Le Bonheur, Plaisir de Merle and Uitkyk. The company sells its products across North America, Europe, Africa, Latin America and Asia-Pacific. It operates through primary production sites, secondary production sites and trading depots in South Africa and trading depots in Namibia. The company also operates distribution outlets in Swaziland, South Africa, and Botswana. Distell is headquartered in Stellenbosch, Western Cape, South Africa.

Scope

- Detailed information on Distell Group Limited required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Distell Group Limited in the form of a SWOT analysis
- An in-depth view of the business model of Distell Group Limited including a breakdown and examination of key business segments
- Intelligence on Distell Group Limited’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Distell Group Limited, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Distell Group Limited and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Distell Group Limited as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Distell Group Limited’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
Distell Group Limited: Company Overview 8
Distell Group Limited: Overview and Key Facts 8
Distell Group Limited: Overview 8
Distell Group Limited: Key Facts 8
Distell Group Limited: Key Employees 9
Distell Group Limited: Key Employee Biographies 10
Distell Group Limited: Major Products and Services 11
Distell Group Limited: Company History 12
Distell Group Limited: Management Statement 14
Distell Group Limited: Locations and Subsidiaries 17
Distell Group Limited: Key Competitors 19
Distell Group Limited: Company Analysis 20
Distell Group Limited: Business Description 20
Distell Group Limited: SWOT Analysis 21
Distell Group Limited: SWOT Overview 21
Distell Group Limited: Strengths 21
Distell Group Limited: Weaknesses 22
Distell Group Limited: Opportunities 22
Distell Group Limited: Threats 23
Distell Group Limited: Corporate Financial Deals Activity 24
Distell Group Limited: Financial Deals Overview 24
Distell Group Limited: Targets and Partners 26
Distell Group Limited: Top Deals 2014 – 2018YTD* 27
Distell Group Limited: Mergers and Acquisitions 28
Distell Group Limited: Capital Raising 29
Distell Group Limited: Partnership 30
Distell Group Limited: Divestments 31
Distell Group Limited: Private Equity and Ownership 32
Distell Group Limited: Recent Developments 33
Distell Group Limited: News and Events Summary 33
Distell Group Limited: Business Expansion 34
Distell Group Limited: Corporate Governance 34
Distell Group Limited: Financial Deals 34
Distell Group Limited: Financial Performance 35
Distell Group Limited: Strategy and Operations 35
Appendix 36
Contact Us 36
Methodology 36
About MarketLine 37

List of Tables
Table 1: Distell Group Limited: Key Facts
Table 2: Distell Group Limited: Key Employees
Table 3: Distell Group Limited: Company History
Table 4: Distell Group Limited: Locations and Subsidiaries
Table 5: Distell Group Limited: Key Competitors
Table 6: Distell Group Limited: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Distell Group Limited: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: Distell Group Limited: M&A Average Deal Size - Value (US$m)
Table 9: Distell Group Limited: Targets and Partners
Table 10: Distell Group Limited: Top Deals 2014 - 2018YTD*
Table 11: Distell Group Limited: M&A Volume and Value Trend (2014 - YTD*2018)
Table 12: Distell Group Limited: M&A Activity by Geography (2014 - YTD*2018)
Table 13: Distell Group Limited: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 14: Distell Group Limited: Capital Raising by Deal Type (2014 - YTD*2018)
Table 15: Distell Group Limited: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 16: Distell Group Limited: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 17: Distell Group Limited: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 18: Distell Group Limited: Divestments by Geography (2014 - YTD*2018)
Table 19: Distell Group Limited: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Table 20: Distell Group Limited: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)
Table 21: Distell Group Limited: News and Events Summary
Table 22: Distell Group Limited: Business Expansion
Table 23: Distell Group Limited: Corporate Governance
Table 24: Distell Group Limited: Financial Deals
Table 25: Distell Group Limited: Financial Performance
Table 26: Distell Group Limited: Strategy and Operations

List of Figures
Figure 1: Distell Group Limited: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Distell Group Limited: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Distell Group Limited: M&A Average Deal Size - Value (US$m)
Figure 4: Distell Group Limited: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: Distell Group Limited: M&A Activity by Geography (2014 - YTD*2018)
Figure 6: Distell Group Limited: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 7: Distell Group Limited: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 8: Distell Group Limited: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 9: Distell Group Limited: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 10: Distell Group Limited: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 11: Distell Group Limited: Divestments by Geography (2014 - YTD*2018)
Figure 12: Distell Group Limited: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Figure 13: Distell Group Limited: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Distell Group Limited：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Humabs BioMed SA：製薬・医療：M&Aディール及び事業提携情報
    Summary Humabs BioMed SA (Humabs), a subsidiary of Vir Biotechnology Inc, is an antibody therapeutics biotechnology company that discovers and develops human monoclonal antibodies. The company’s pipeline programs include Flu A virus, ebola virus, HBV, rabies virus, JCV, dengue, and others. It develo …
  • Bilfinger Tebodin B.V.：企業の戦略的SWOT分析
    Bilfinger Tebodin B.V. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Cost Plus Inc：企業の戦略的SWOT分析
    Cost Plus Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Hanmi Pharmaceuticals Co Ltd (128940)：医療機器：M&Aディール及び事業提携情報
    Summary Hanmi Pharmaceuticals Co Ltd (Hanmi Pharma), a subsidiary of Hanmi Science Co Ltd is a developer of prescription drugs and over the counter drugs. The company’s prescription drugs include osteoporosis, antibiotics, antidiarrheal, liver supplements and antiemetics. It provides over the counte …
  • AVBOB Mutual Assurance Society：企業の戦略・SWOT・財務分析
    AVBOB Mutual Assurance Society - Strategy, SWOT and Corporate Finance Report Summary AVBOB Mutual Assurance Society - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Matalan Retail Limited：企業の戦略・SWOT・財務情報
    Matalan Retail Limited - Strategy, SWOT and Corporate Finance Report Summary Matalan Retail Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Mahanagar Telephone Nigam Ltd (MTNL)：企業の財務・戦略的SWOT分析
    Mahanagar Telephone Nigam Ltd (MTNL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Baron Oil Plc (BOIL)：石油・ガス：M&Aディール及び事業提携情報
    Summary Baron Oil Plc (Baron Oil), formerly Gold Oil PLC is an oil and gas exploration and production company. The company identifies and develops crude oil and natural gas interests in Latin America including Peru and Colombia. It holds working interests of Nancy Burdine Maxine oil field, oil and g …
  • TreeHouse Foods, Inc.：企業の戦略・SWOT・財務情報
    TreeHouse Foods, Inc. - Strategy, SWOT and Corporate Finance Report Summary TreeHouse Foods, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Western Areas Limited：企業の戦略・SWOT・財務分析
    Western Areas Limited - Strategy, SWOT and Corporate Finance Report Summary Western Areas Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Grupo Farma：企業の戦略的SWOT分析
    Grupo Farma - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • ZTE Corporation：企業のM&A・事業提携・投資動向
    ZTE Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ZTE Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • The US Oncology Network：企業の戦略的SWOT分析
    The US Oncology Network - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Kaleido Biosciences Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Kaleido Biosciences Inc (Kaleido Biosciences) is a developer of human microbiomes for the treatment of infectious, rare genetic, inflammatory, oncology and metabolic diseases. The company’s human microbiome is a metabolic engine which is developed from healthy and diseased humans using vario …
  • Ingenico SA：戦略・SWOT・企業財務分析
    Ingenico SA - Strategy, SWOT and Corporate Finance Report Summary Ingenico SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Planung Transport Verkehr AG：企業の戦略的SWOT分析
    Planung Transport Verkehr AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Koch Industries Inc：企業の戦略的SWOT分析
    Koch Industries Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • GW Pharmaceuticals Plc (GWP)：企業の財務・戦略的SWOT分析
    GW Pharmaceuticals Plc (GWP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Verona Pharma Plc (VRP)：製薬・医療：M&Aディール及び事業提携情報
    Summary Verona Pharma Plc (Verona Pharma) is a clinical-stage biotechnology company, which focuses on the research, discovery and development of first-in-class therapeutic drugs for the treatment of chronic respiratory and inflammatory diseases. The company's lead candidate, RPL554 is a bronchodilat …
  • Bespak Europe Ltd：企業の製品パイプライン分析2018
    Summary Bespak Europe Ltd (Bespak), a subsidiary of Consort Medical plc is a medical device company that provides inhalation systems. The company provides products such as inhalation devices, injectables, medical check valves and nasal products. Its inhalation devices comprise dose counting actuator …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆